CD40 Monoclonal Antibody (5C3), Functional Grade, eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0476731
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $122.65
About this award
The University of Virginia awarded contract A207_PO-0476731 to Life Technologies Corporation on September 3, 2026. The contract value totals $122.65 and encompasses the procurement of specialized laboratory reagents. The primary deliverable under this award is one unit of CD40 Monoclonal Antibody (5C3), Functional Grade, manufactured by eBioscience, to be delivered to Claudia Marcela Rival at the contracting organization.
The line item pricing reflects a unit cost of $122.65 for the monoclonal antibody product, representing the cumulative contract value. As a research-grade immunological reagent, this antibody product supports laboratory and research operations within the University of Virginia's operations in Virginia. The award documents do not specify an explicit performance period or annual value separate from the cumulative contract amount, indicating this represents a discrete purchase order transaction rather than a multi-year requirements contract.
Line items
| Item | Total |
|---|---|
| CD40 Monoclonal Antibody (5C3), Functional Grade, eBioscience | $122.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0476731?
Contract A207_PO-0476731 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on September 3, 2026.
How much is contract A207_PO-0476731 worth?
Its cumulative value is $122.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award